| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 15955-389-01 | 15955-389 | HUMAN PRESCRIPTION DRUG | Metronidazole | Metronidazole | TABLET | ORAL | 20190626 | N/A | ANDA | ANDA208681 | Alembic Labs LLC | METRONIDAZOLE | 500 mg/1 | 100 TABLET in 1 BOTTLE (15955-389-01) |
| 15955-389-05 | 15955-389 | HUMAN PRESCRIPTION DRUG | Metronidazole | Metronidazole | TABLET | ORAL | 20190626 | N/A | ANDA | ANDA208681 | Alembic Labs LLC | METRONIDAZOLE | 500 mg/1 | 500 TABLET in 1 BOTTLE (15955-389-05) |
| 15955-388-01 | 15955-388 | HUMAN PRESCRIPTION DRUG | Metronidazole | Metronidazole | TABLET | ORAL | 20190626 | N/A | ANDA | ANDA208681 | Alembic Labs LLC | METRONIDAZOLE | 250 mg/1 | 100 TABLET in 1 BOTTLE (15955-388-01) |
| 15955-388-05 | 15955-388 | HUMAN PRESCRIPTION DRUG | Metronidazole | Metronidazole | TABLET | ORAL | 20190626 | N/A | ANDA | ANDA208681 | Alembic Labs LLC | METRONIDAZOLE | 250 mg/1 | 500 TABLET in 1 BOTTLE (15955-388-05) |